Takeda Pharmaceutical Company Limited– COCKPI-T® Funding 2020

In order to accelerate open innovation activities, Takeda leads an open grant competition program COCKPI-T® (Co-Create Knowledge for Pharma Innovation Takeda) where Takeda invites innovative research proposals corresponding to nominated Areas of Interest from researchers/companies and support them financially to confirm their research concepts.

Mochida Pharmaceutical Co., Ltd. – MOIRe (Mochida Open Innovation Research)

Mochida Pharmaceutical is a smaller listed Japanese pharma company. This is the first time Mochida has explored project opportunities in Australia. "Mochida has implemented “MOIRe”, an open innovation program for drug discovery based on proposals from academic researchers since 2019 in Japan. From this year, Mochida welcomes applications from overseas researchers with a great interest in connecting drug discovery seeds to pharmaceutical development for collaborative research."

NFMRI Commercialisation Seminar -The-commercialisation journey learnings from Cincera Therapeutics

National Foundation for Medical Research and Innovation (NFMRI), Monash University and Brandon Capital Partners invite you to a Commercialisation Seminar.

The Commercialisation Journey - Learnings from Cincera Therapeutics

The Monash Innovation team are organising a seminar on Wednesday, 26 February about (medical) research translation/commercialisation with speakers from NFMRI, MRCF and Monash (Researcher and Monash Innovation).